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1. Introduction  
Post-translational modifications (PTMs) enable proteins carryout multiple biological 
functions. PTMs facilitate and regulate various protein functions by changing the chemical 
and physical characteristics of a protein, which affect its stability, cellular localization, and 
its interaction with other proteins as well as non-protein molecules which endow the 
protein-protein interactions, cellular localization and with new or altered biological 
activities. Understanding how and to what extent cellular proteins are post-translationally 
modified, at which sites on the protein, how the modifications affect the stoichiometry of the 
protein sequence, and what the functional consequences of each of the modifications are, 
therefore becomes indispensible for understanding cellular function and regulation of a 
protein. Recent advances that facilitated combining affinity-based enrichment of low 
abundant and novel PTMs with peptide sequencing with tandem mass spectrometric 
analysis have increased its speed and sensitivity of analytical approaches. Although it has 
been demonstrated that mass spectrometry can be an ideal tool for both qualitative and 
quantitative analysis of protein modifications, comprehensive identification of PTMs using 
mass spectrometry (MS) in a high-throughput manner remains a highly challenging task 
because of the diversity, dynamic complexities, low abundance and heterogeneity of PTMs. 
In addition, difficulties in interpreting tandem MS spectra for peptide sequencing, poor 
peptide fragmentation, and surprising appearance of totally unexpected modifications, 
among others, have compounded this challenge and limited the application of mass 
spectrometry to the identification of a few types of PTMs.  
We will describe in this chapter, a strategy we have been employing successfully for rapid, 
efficient and sensitive identification of diverse and novel PTMs occurring in mammalian 
biological systems in vivo. Our strategy includes: separation of unmodified and modified 
proteins on 2-dimensional gel electrophoresis (2D-PAGE); and detection of low abundant 
peptide modifications employing a selectively excluded mass screening analysis (SEMSA) of 
unmodified peptides during LC-ESI-q-TOF MS/MS through replicated runs (Seo et al., 
2008), in conjunction with a searching algorithm MODi (Kim et al., 2006; Na et al., 2008) and 
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DBond (Choi et al., 2010), which we developed. We will also provide examples of novel 
some low abundant cysteine modifications which we identified in cellular proteins 
employing our strategy (Lee et al., 2009; Hwang et al., 2009; Jeong et al., 2011).   
Since it is difficult in many cases, to predict the type and position of modifications from 
autotranslated DNA sequences, it is highly important in the postgenomic era, to 
experimentally obtain this information about PTMs. For, the type and position of PTMs 
differ, depending on the organism, cell type, signaling process and its kinetics. Proteomics 
allows deciphering the global picture of protein-related processes in the cell. But proteomics 
cannot be successfully employed without defining the dynamic PTM maps, which in turn 
requires the availability of a fast, reliable, and sensitive procedure for PTM characterization. 
We believe that the highly sensitive and efficient strategies for unrestrictive blind PTM 
identification that will be described in this chapter will help develop such PTM maps.  
2. Diversity of post-translational modifications and their identification using 
mass spectrometry  
Structural changes in proteins can occur from various events including genomic mutations, 
alternative splicing, proteolytic cleavage, chemical and enzymatic modifications in amino 
acid side chains. These changes occurring inside cells and tissues cannot be recognized in 
genomic level, other than by proteomic analysis which makes it possible to identify these 
alternations. Since these modifications are highly diverse, many proteomic approaches are 
required to identify them. This review will describe the diverse characteristics of PTMs in 
proteins and the analytical approaches including mass spectrometry employed to identify 
them. 
2.1 Cellular protein modifications 
Modifications in the side chain of amino acids of proteins can alter the protein’s charge, 
polarity and spatial features, and induce conformational changes which in turn cause 
changes in a variety of protein characteristics. These modifications can occur reversibly or 
irreversibly, and be mediated by enzymes or non-enzymatic way. In addition, many 
changes at the genomic level such as point mutation, deletion and insertion, alternative 
splicing etc. induce alterations in amino acid sequences. Identification of these changes 
may require different analytical MS methodologies, depending on the type of the 
modification.  
2.1.1 Amino acid substitution  
Amino acid substitution, which can occur by point mutation in the genome, or chemical 
conversion of one amino acid to another, is involved in 346 of the listed 900 modifications in 
the database of protein modifications for mass spectrometry, UniMod (www.unimod.org). 
The Human Gene Mutation Database (www.hgmd.org), as of August 2011, lists more than 
113,000 mutations of 4,122 human genes, which include missense/nonsense mutation, 
splicing, small and gross deletion/insertion, complex rearrangement and repeat variation. 
Although a single amino acid substitution usually does not seem affect a protein’s structure 
in most cases, several proteins are known in which a change in single amino acid change 
caused significant changes in the protein structure and stability. An example is a single 
mutation in hemoglobin causes sickle cell anemia, one of several monogenic diseases.  
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Another way to occur amino acid substitution is by chemical conversion of one amino acid 
to another, for example, Asn and Gln can be converted to Asp and Glu by deamination. Cys 
residues are converted to Ser during oxidative stress (Jeong et al., 2011). Mass spectrometry 
has been extremely useful in identifying unexpected amino acid substitutions and deletion 
and insertion of amino acids (Fig. 1). However, finding unknown substitutions with routine 
peptide sequencing in conjunction with tandem MS is not to easy, because MS/MS spectra 
searching algorithm matches only known sequences. In order to find these unexpected 
amino acid changes, in MS/MS spectra, it is necessary to carry out de novo partial 
sequencing of a peptide from an MS/MS spectrum. To find unknown amino acid changes, 
we suggest using the searching algorithm MODi combined with peptide sequencing using 
tandem MS.  
2.1.2 Alternative splicing 
Insertion and deletion of large amino acid sequences can markedly affect the protein 
structure, in contrast to changes in single amino acid residues which mostly do not. 
Alternative splicing can occur in a number of ways including exon skipping, exon insertion, 
alternative 5’ initiation, 3’ termination and even intron inclusions. About 74% of multi-exon 
genes produce alternatively spliced protein variants in humans. These PTMs result in 
proteins differing in binding affinity, enzymatic activity, localization within the cell, and 
stability. Alternative splicing therefore, is a common phenomenon in biology. Existence of 
the alternatively spliced variants can be detected only at the protein level. However, it is not 
easy to find spliced variants without separating each variant population. 2D-PAGE is an 
useful tool to separate the different variants because of their differences in their charges 
(isoelectric points) and molecular weights (Fig. 1). Separation of each population of protein 
variants is a prerequisite for employing mass spectrometry to identify the sequence changes. 
By comparing the chromatogram of each population, it is possible to find peptide products 
generated from alternative splicing, and then de novo sequencing the differential peptides.  
2.1.3 Proteolytic cleavage  
Proteolytic cleavage is obviously an irreversible protein modification. Proteins can be 
cleaved by various proteolytic enzymes, which are classified into serine proteases, cysteine 
proteases, aspartic acid proteases and metalloprotease, depending on their active sites of 
action. Employing genome sequence analysis, 553 proteases were identified in the human 
genome: 203 Ser proteases, 143 Cys proteases, 21 Asp proteases and 186 metalloproteases. 
Since the substrate specificity of each protease is not known in many cases, the proteolytic 
products can be further identified only at protein level. Unexpected cleavage products are 
not easy to detect without mass spectrometry (Fig. 1). Full peptide sequencing with tandem 
MS is the only way to characterize the cleaved products using the same strategy employed 
to detect the alternative splicing variants.  
2.1.4 Enzymatic modifications 
Cellular protein modifications are designed by nature to initiate and regulate essential 
cellular processes. The mechanisms for PTM regulation are not fully understood because of 
their complexity. More than 200 kinds of enzymes (>5% of total proteins) have been shown 
to be involved in catalyzing the various chemical modifications of protein side chains. In the 
human genome, it has been shown that more than 500 proteases, more than 500 protein 
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Fig. 1. Protein amino acid sequence changes with various ways generate unexpected peptide 
fragments in MS analysis.   
kinases, more than 150 protein phosphatases, 5 class methyltransferases, a series of 
acetyltransferase and deacetylase, oxidoreductases, E1, E2, E3 for ubiquitination, 
sumoylation and neddylation, operate among others. Since most enzyme induced protein 
modifications are reversible, they are readily removed during the biological processes after 
they function as signalling molecules.  
Enzymatic modification of amino acid side chains occurs in various ways depending on the 
species of amino acids, as shown in Table 1. For example, phosphorylation at –OH in Ser, 
Thr and Tyr residues, can be promoted by various protein kinases and one third of total 
human proteome is estimated to comprise substrates of various proteins kinases, predicted 
to number more than 500. Phosphorylated proteins serve as substrates of kinases. They are 
readily dephosphorylated by phosphatases. Tyrosine kinase receptors (e.g. PDGF receptor, 
VEGF receptor) are auto-phosphorylated by ligand binding and transduce the signalling as 
turn ‘on’ switch, and later dephosphorylated by phosphatases, as turn ‘off’ switch. These 
reversible modifications act as on/off switches in various signalling pathways by 
controlling phosphorylation and dephosphorylation. Thus it becomes important to identify, 
which residues are phosphorylated, which kinase acts on them, how long signalling is 
turned on and which phosphatases are involved in the turn off.  
In addition to kinases and phosphatases which signal phosphorylation/dephosphorylation, 
other enzyme pairs are involved in reversible modifications; e.g. acetyltransferase and 
deacetylase, acyltransferase and deacylase, methyltransferase and demethylase, 
ubiquitinating and deubiquitinating enzymes, chemical oxidation and peroxidase and 
reductase, glycosylase and deglycosylase, among others. Irreversible modifications are also 
possible, for example, crosslinkiing of the proteins by transglutaminase. Although many 
modifications have been identified thus far, an enormous number of unknown protein 
modifications are waiting to be discovered. Mass spectrometry offers an useful analytical 
approach to identifying and quantifying the unknown novel modifications, modification 
sites, and the accompanying structural changes. The relevant methodologies are detailed in 
section 2.2.  
2.1.5 Non-enzymatic chemical modifications  
Protein modifications can occur inside cells by chemical reactions rather than by enzymatic 
action. Oxidation of Cys, Met, Pro, Trp residues is promoted by reactive oxygen species 
(ROS) resulting in loss of protein activity or alteration of the protein’s biological function by 
modifying its cellular localization and interactions with other proteins. Nitrosylation, 
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formation of metabolic protein adducts e.g. 4-hydoxynonenal (HNE) adducts involving His, 
Cys, Lys, chemical adducts with biotin, lipoic acid and phosphopantetheine are well defined 
modifications (Table 1). Many metabolite adducts of proteins will be further investigated 
using de novo sequencing using tandem MS and searching algorithm.  
 
PTM type 
Modified amino 
acid residue 
Monoisotopic 
mass change 
Remarks 
Phosphorylation S T Y H D +79.966331 Appearance of ΔM = -97.976896 Da peak for 
dehydration in the phosphorylation sites of 
Ser and Thr.  
Use phosphatase inhibitor in sample 
Cysteine oxidation 
Dehydroalanine 
Cys to Ser 
Disulfide 
Sulfenic acid 
Sulfinic acid 
Sulfonic acid 
Thiosulfonic acid 
Selenylation 
C-nitrosylation  
Glutathionylation 
C  
-33.987721 
-15.977156 
-2.0145 
+15.994915 
+31.98983 
+47.984745 
+63.961901 
+79.916520 
+28.990164 
+305.068156 
Careful for artifactual oxidation 
 
 
 
 
 
 
 
Cys-S-SeH 
Acetylation K N-term +42.010565 Change (+) charge to neutral  
Use deacetylase inhibitors in sample 
Acylation 
Octanoylation 
Farnesylation 
Palmitoylation 
Geranyl-geranylation 
Retinal 
Diacylglycrol 
 
S T 
C 
C K N-term 
C K N-term 
K 
C 
 
+126.104465 
+204.187801 
+238.229666 
+272.250401 
+266.203451 
+576.511761 
Increase hydrophobicity of protein to be 
anchored into membrane 
Ubiquitination  K +114.042927 Ubiquitin C-term Gly-Gly adduct 
Use proteasome inhibitor in sample 
Glycosylation 
Fucose 
Hexoseamine 
Hexose 
O-GlcNAcylation 
 
S T 
N T 
N T 
N S T 
 
+146.057909 
+161.068808 
+162.052824 
+203.0743 
 
 
 
 
N-acetylhexoseamine 
Methylation 
Mono-methylation 
Di-methylation 
Tri-methylation 
 
K R 
K R 
K R 
 
+14.01565 
+28.0313 
+42.04695 
Sterically bulky without charge change 
Sulfonation S T Y C +79.956815  
Deamidation  N Q  +0.984016 Amino acid substitution to D E 
Chemical adduct 
Allysine  
Oxidation 
Hypusine 
4-hydroxynonenal  
Lipoyl 
 
K 
P D K N P Y R 
K 
C H K 
K  
 
-1.031634 
+15.994915 
+87.068414 
+156.115030 
+188.032956 
 
Lys oxid to aminoadipic semialdehyde 
Oxidation or hydroxylation 
 
HNE 
N-term  
Met-loss 
Met-loss + Acetyl 
 
M 
M 
 
-131.040485 
-89.029920 
 
N-term Met removal by aminopeptidase 
Acetylation in new N-term after Met loss 
Artifactual adduct 
Propionamide 
Carbamidomethyl   
 
C K N-term 
C K N-term H D  
 
+71.037114 
+57.021464 
 
Acrylamide adduct in PAGE 
Iodoacetamide derivative  
Table 1. The list of identified post-translational modifications.   
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2.2 Identification of post-translational modifications by mass spectrometry  
Protein modifications play key role in protein structure, stability, its interactions and cellular 
localizations. MS is an ideal analytical tool for analyzing protein sequences, identifying 
many unknown post-translational modifications, sites modified, and amino acid sequences 
inserted, deleted or repalced. Studies employing MS along with other techniques, have 
recorded more than 900 PTMs in UniMod database (www.unimod.org). Number of PTM list 
in this database is rapidly increased. This informations on the nature of PTMs should 
facilitate a fuller understanding protein structure and function. A list of reported PTMs and 
the corresponding sites of amino acids, monoisotopic mass change by PTM, and sample 
preparation for identifying each PTM is shown in Table 1. These proteomic studies for PTM 
analysis can be divided into two groups. One group consists of large scale analysis of one 
kind PTM after enriching the modified proteins and identifying PTMs, necessitated by low 
abundance of modified proteins. The second group comprises comprehensive analyses of 
multiple modifications in one protein because the diversity of modifications in the chosen 
protein (Fig. 2).  
2.2.1 Large scale analysis of same type of PTMs in many proteins 
Large scale identification of PTMs is not easy problem to be solved because each 
modification has its distinct and unique chemical property including chemical affinity, 
solubility, charge and hydrophobicity. In order to identify one kind of PTM in many 
proteins with high throughput analysis, the enrichment of modified proteins or peptides 
was combined with peptide sequencing with tandem MS. Affinity-based enrichment of 
post-translationally modified proteins and peptides can provide to increase the relative 
abundance of a selected PTM in the sample.  
Several studies have reported the systemic identification of same PTM to understand wide 
signaling cascade (Table 2). Phosphorylation, the most extensively studied PTM, has been 
reported in more than 10,000 proteins, variously concerned with specific signaling, in cell 
cycle, cancer, receptor function, and stress responses (Olsen et al., 2010; Dephoure et al., 2008; 
Rikova et al., 2007; Kim et al., 2002, Kim et al., 2007a and 2007b). Intriguingly, although 
phosphorylation seems to play a pivotal role in various signal cascades, phosphorylated 
peptides constitute minor fraction of the total protein mileau. Due to the low abundance of 
phosphopeptides and low degrees of phosphorylation, enrichment phosphopeptides is 
essential prior to MS analysis (Fig. 2A). There are several strategies for enrichment of 
phosphoproteins, including immobilized metal ion affinity chromatography (IMAC), 
titanium dioxide (TiO2) chromatography, and immunoaffinity chromatography with anti-pY 
antibodies (Thingholm et al., 2009). These enrichment techniques themselves have 
advantages and disadvantages, related to different specificities of the proteins under study. 
Immunoaffinity chromatography is a traditional biochemical technique, based on the 
binding of proteins or peptides to phospho-specific antibodies. Highly selective phospho-
specific antibodies are available that can be utilized for the enrichment of phosphorylated 
proteins prior to analysis by MS. IMAC takes advantage of the affinity of chelated (Fe3+, 
Al3+, Ga3+, or Co2+) ions towards the negative phosphate group of phosphopeptides. 
Titanium dioxide chromatography utilizes the affinity for phosphate ions in aqueous 
solutions. Titanium dioxide chromatography sometimes can be combined with IMAC in 
which mono- and multiply phosphorylated peptides are efficiently enriched from highly 
complex samples. When combined with other enrichment methods, the method offers an 
efficient enrichment strategy for phosphoproteomic studies. In another approach, cellular 
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proteins with or without treatment, were separated on 2D-PAGE and phosphorylated 
proteins on Tyr residues were detected by anti-pY antibody, and each spot was analyzed 
with tandem MS (Kim et al., 2007a and 2007b). Separation of modified protein from 
abundant unmodified proteins on 2D-PAGE is an informative way to obtain only modified 
proteins.   
However, attempts to enrich other PTMs have met with limited success. Acetylation of Lys 
residue is another abundant PTM with fundamentally important regulatory function. 
Acetylation occurs as a co-translational and post-translational modification of proteins, such 
as histones, p53 and tubulins. The acetyl group can become attached to either the ǂ-amino 
group at the protein N-terminus or the ε-amino groups of Lys residues and eliminate the 
positive charge of the amino group to make it uncharged. Thus, Lys acetylation, a reversible 
PTM, regulates protein interaction with negatively charged DNA, thereby playing a key 
regulatory role in gene expression. For example, acetylation of histone or p53 inhibits the 
DNA binding and renders DNA more relaxed, and deacetylation reverses this process. 
However, enrichment methods, except for immunoaffinity purification, have not been 
developed thus far. There remains a need for robust methods that can address the 
complexity and dynamic range of the cellular proteome. 
In contrast to phosphorylation and acetylation as small chemical modifications, 
ubiquitination, a PTM involving the covalent attachment of ubiquitin, a 76-residue 
polypeptide, to Lys residue, induce bulk change of protein. Depending on the nature and 
site of linkage, ubiquitination regulates protein degradation, signal transduction, 
intracellular localization and DNA repair. Ubiquitination is readily detected by peptide 
sequencing with tandem MS, because Gly-Gly adduct of ubiquitin C-terminal (+114 Da 
increase) can easily be detected at Lys ubiquitinated residues in tryptic peptides. Most 
common enrichment methodology for ubiquinated proteins is immunoaffinity purification 
employing exogenously tagged ubiquitin (Danielsen et al., 2011). Recent studies have 
employed endogenous ubiquitin enrichment using ubiquitin binding motifs such as 
ubiquitin interacting motif (UIM) or ubiquitin associated (UBA) domain, rather than Ub-
antibody (Manzano et al., 2008). About 200 ubiquitinated proteins binding to UBA domain 
of p62 were identified in Arabidopsis. 
Glycosylated proteins exist as heterogenous populations characterized by a range of 
molecular weight, and play important role in membrane surface localization and as 
receptors by raising the hydrophilicity and changing the surface charge. The O-linked ǃ-N-
acetylglucosamine (O-GlcNAcylation) also plays a vital role modifying Ser and Thr residues 
in many cellular processes, including signal transduction, protein degradation, and 
regulation of gene expression. Since the lectin, Wheat Germ Agglutinin (WGA), has affinity 
for terminal N-acetylglucosamine (GlcNAc) and sialic acid residues, lectin immobilized 
affinity chromatography has been recently used for enrichment O-GlcNAc modified 
peptides (Vosseller et al., 2006). Biotinylated O-GlcNac peptides are captured by avidin 
chromatography (Wang et al., 2010).   
Oxidative modification has emerged as a major PTM involved in oxidative stress. 4-
Hydroxy-2-nonenal (HNE), generated during lipid peroxidation, modifies proteins. 4-HNE 
adducts are commonly enriched by immunoaffinity chromatography or solid-phase 
hydrazide enrichment strategy (Mendez et al., 2010; Roe et al., 2007). Other oxidation 
adducts of reactive Cys residues play key roles in cellular regulations. Recently dimedone, 
and chemicals that specifically label sulfenic acid, have been used to enrich sulfenic acid 
using biotin tagged dimedone, and to identify ROS sensitive Cys residues (Giron et al., 2011, 
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Seo YH et al., 2009, Leonard et al., 2009). Large scale proteomic identifications of proteins 
containing the same kind of PTM, e.g., phosphorylation or acetylation, can be interesting if 
the relationship between a specific modification and biological function can be established.   
 
 
Fig. 2. Schematic diagram to identify one type modification in cellular proteins (A) and 
comprehensive modifications in one protein (B).  
2.2.2 Comprehensive identification of multiple PTMs in the same protein by MS 
If the same protein has multiple and diverse functions, one can hazard the assumption that 
it exists in several forms and contains different PTMs. Comprehensive identification of 
PTMs in a single protein can therefore help understand how the protein exerts multiple 
biological functions of multiply modified proteins as shown in Fig. 2B. However, it is not an 
easy task to clearly identify the PTMs in the same protein, because biological samples of 
proteins are mixtures of unmodified and modified populations, with unmodified molecules 
abundantly predominating and the much less abundant modified molecules. A 100% 
peptide coverage with MS/MS is required for identifying all modifications.  
The low abundant PTMs can only be identified after adequately enriching their populations. 
When complex enrichment methods are needed, use of 2D-PAGE based separation in 
combination with mass spectrometry is beneficial. 2D-PAGE separates proteins based on 
their isoelectric points and molecular mass, and makes it possible to separate various 
modified proteins, spliced variants and proteolytic cleaved fragments. Proteomics has been 
traditionally exploited power of 2D-PAGE, to separate proteins, especially coupling it with 
MALDI-TOF MS, for the qualitative and quantitative analysis of proteins in complex 
extracts. However, the limitations of this approach in terms of throughput analysis of 
protein mixes have required the development of other proteomics approaches, based on 
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separation of peptides rather than of proteins, or on direct protein identification and 
selection on dedicated arrays (protein chips). However, 2D-PAGE based separation is 
adequate in the comprehensive identification of PTMs because it can show the range of 
complex PTMs. 
 
PTM type 
(Mass Shift) 
Enrichment 
methods 
# of sites identified 
Biological Association 
of the protein 
References 
Phosphorylation 
(79.9663) 
IMAC, and TiO2 
20,443 sites on 6027 
proteins
cell cycle Olsen et al., 2010 
 
1400 sites on >1000 
proteins
Mitosis Dephoure et al., 2008 
 
IMAC 654 sites 
cAMP/vasopressin-
dependent signaling 
pathways
Gunaratne et al.,2010 
 
Immuno-affinitiy 
purification with
4551 sites on 2550 
proteins
Lung cancer Rikova et al., 2007 
Anti-pY Ab 628 sites Cancer cells Rush et al., 2005 
 
2D-PAGE, Anti-pY 
Ab
81 proteins Heat shock Kim et al., 2002 
 
95 proteins 
Endothelial cells
VEGF-, ROS-signaling
Kim et al., 2007a 
 
66 proteins 
Angiopoietin-1 
signaling
Kim et al., 2007b 
Acetylation 
(42.0105) 
Immuno-affinitiy 
purification with
3600 sites on 1750 
proteins
Human acute myeloid 
leukemia cell line
Choudhary et al., 
2009 
 
Anti-acetyl Lys Ab
1981 sites on 1013 
proteins
Drosophila Weinert et al., 2011 
1000 sites Human liver tissue Guan et al., 2010 
Ubiquitination 
(114.0429) 
Tagged ubiquitin 753 site 471 proteins 
Human osteosarcoma 
cells
Danielsen et al., 2011 
110 sites 72 proteins Peng, J. et al., 2003 
Sumoylation Tagged SUMO 
339 putative 
polySUMO
polySUMO conjugates Bruderer et al., 2011 
17 sites on 205 proteins HEK293 cells Galisson et al., 2010 
14 sites on 12 proteins Blomster et al., 2010 
O-GlcNAcylation 
(203.0793) 
Lectin-affinity 
purification
141 sites on 64 proteins Cytokinesis Wang et al., 2010 
 
65 sites 
Postsynaptic density 
preparation.
Vosseller et al., 2006 
4-HNE 
(156.1150) 
Immunoaffinity 12 proteins Human RBCs Mendez et al., 2010 
 
Solid-phase 
hydrazide 
enrichment
125 sites on 67 proteins
 
Roe et al., 2007 
 
2D-PAGE, MS 
Early Alzheimer's 
disease
Redd et al., 2009 
Sulfenic acid 
(15.9949) 
Biotin-dimedone
purification
39 proteins HeLa cells Leonard et al., 2009 
2D-PAGE 35 proteins Hypertensive Rat Tyther et al., 2010 
biotinylated 15d-
PGJ2 
(316.2038) 
Streptoavidin 
affinity 
12 proteins Neuroblastoma Aldini et al., 2007 
Table 2. Large scale identification of each PTM in proteins from divergent sources and 
pathways. 
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For example, phosphorylated, acetylated, glycosylated and oxidized proteins move in acidic 
direction, ubiqutinated and sumoylated proteins move upward by increasing molecular 
weight and disulfide bonded proteins move either upward with intermolecular disulfide or 
downward with intramolecular disulfide bond. This information can allow the prediction of 
the type of PTM and overcomes the limitations due to the complexity of PTMs. 
Following the separation of the heterogeneous populations of modified proteins on 2D-
PAGE, we try to obtain comprehensive PTM information via replicate nanoLC-ESI MS/MS 
analysis by raising the modified peptide coverage (Seo et al., 2008). To facilitate the 
characterization of PTMs as much as possible, we devised the strategy of selective exclusion 
acquisition in replicate run analysis. In data dependent acquisition (DDA) mode, most 
intense precursor ions are redundantly acquired in nanoLC-ESI MS/MS run. If the exclusion 
list is not used, identification of low-intensity ions in the presence of high-intensity ions 
would be far less successful in randomly repeated runs. The number of obtainable MS/MS 
spectra is limited in a single run analysis, because we select MS/MS spectra having 
appropriate quality and quantity by optimizing the experimental procedure including 
sensitivity, scan time, number of ion channel, time for return to MS scan from MS/MS scan, 
elution time in LC etc. This is the reason for selectively excluding unwanted high-intensity 
MS/MS data generation. Exclusion methodology is a way to separate wanted peptides from 
unwanted ones. The overall scheme of Selectively Excluded Mass Screening Analysis 
(SEMSA) is shown in Fig. 3. An exclusive implementation using this unmodified peptide 
library, resulted in efficient identification of low abundant PTMs (Fig. 4). As the SEMSA 
progressed, exclusion list is cumulated and then separation of unwanted peptide can 
ameliorate the quality of MS/MS spectra. The LC-MS procedure is repeated three times to 
obtain more MS/MS data. The MS data of the first run are then processed by ProteinLynx 
v2.1 for peak deconvolution and peak list generation. The resulting MS/MS spectra are then 
generated and submitted to Mascot and ProteinLynx database searches to obtain peptide 
identifications. Only unmodified peptides now serve as candidates for a precursor exclusion 
list, in terms of m/z and LC run times in the subsequent run. After the peak list of the 
second separation is generated, the peaks are matched to peptides previously identified and 
included in the exclusion list are automatically blocked from the peak selection prior to 
MS/MS acquisition. The ranges of tolerance windows of excluding peak are typically 
determined by mass accuracy and resolution in the MS scan and peak widths in the 
chromatogram. This PTM specific exclusion strategy enables less intense PTM peptides to be 
identified, thereby enhancing confidence level of PTM identifications.  
To determine whether the GAPDH spots on 2D-PAGE have differential modifications, we 
exhaustively examined the PTMs in each population using SEMSA (Seo et al., 2008). Diverse 
PTM populations were identified in various peptides (Fig. 5). Especially, multiple 
modifications of Cys residue in the peptide containing active site (152CTTNC156) were clearly 
demonstrated: intra-disulfide between 152C and 156C, oxidation to cysteic acid (152C), and 
transformation of Cys to Ser (152C). Simultaneously, 247C was shown to transform to 
sulfinic acid, mainly dehydroalanine and cysteic acid. This indicates that reactive Cys 
residues in GAPDH can be oxidized to various oxidation states depending upon tertiary 
structural environments. Results of these studies clearly established the exact oxidation 
sites, oxidation species, and the levels of oxidation states. This strategy was applied for 
finding many low abundant modifications including phosphorylation, acetylation, 
glutathionylation and some novel modifications (Hwang et al., 2009; Lee et al., 2010; Jeong et 
al., 2011). 
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Fig. 3. Schematic diagram of SEMSA to enrich the low abundant modified peptides by 
excluding abundant unmodified peptides obtained in the first identification in the 2nd and 
3rd runs. 
 
 
Fig. 4. Comparison of MS/MS spectra of chosen low-density peptides under without (A) 
and with (B,C) SEMSA strategy (cited from Seo et al., 2008). 
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Combination of 2D-PAGE for separating modified populations and MS/MS analysis using 
SEMSA, makes it possible to identify low abundant modified peptides and to raise the 
identified peptide coverage nearly over 90%. 
2.2.3 Bioinformatic tools for identifying multiple and novel modifications  
The types and sites of PTMs in a protein vary widely. Although MS allows rapid 
identification of many types of PTMs, data analysis and interpretation of MS/MS spectra for 
identification of PTMs remain a major challenge. Most of the available search tools accept 
only a few types of PTMs as input. We have developed interpretative tools called MODi (Na 
et al., 2008) and DBond (Choi et al., 2010) for rapidly interpreting tandem mass spectra of 
peptides with all known types of PTMs simultaneously without limiting a multitude of 
modified sites.  
Early approaches to PTM identification using MS/MS involved exhaustive searches of all 
possible combinations of PTMs for each peptide from a protein database (Eng et al., 1994; 
Perkins et al., 1999). Because the search space grows exponentially as the number of PTMs 
increases, these early approaches performed a restrictive search that took into account only a 
few types of PTMs during data analysis, ignoring all others. Investigators were obliged to 
guess the PTMs expected to exist in a sample prior to a search, and many potentially 
important PTMs may have been overlooked. A few tools were recently introduced for blind 
PTM search. MS-Alignment (Tsur et al., 2005) predicts PTMs expected in a sample by 
spectral alignment between a database peptide and a spectrum followed by InsPecT search 
(Tanner et al., 2005).  ModifiComb (Savitski et al., 2006) introduced a ΔM histogram between 
unassigned spectra and base peptides found in a database. These blind approaches predict 
PTMs based on the frequency of mass shifts (indicating potential PTMs) in a sample. Thus, 
they all have the intrinsic weakness of missing rare or infrequently observed PTMs that 
might provide important clues to understanding the function of a protein. Although many 
approaches have been developed to take into account several types of PTMs, most of them 
assume that there will be a single variable PTM per peptide and ignore peptides with 
multiple modifications. MODi (pronounced “mod eye”) is essentially a sequence tag 
approach (Mann et al., 1994; Tabb et al., 2003) (Fig. 6). It constructs a partial sequence of a 
peptide from an MS/MS spectrum using de novo sequencing. MODi differs from previous 
approaches in that it simultaneously uses multiple sequence tags derived from a spectrum 
by introducing a notion of a tag chain, a combination structure of multiple sequence tags. A 
tag chain offers an effective localization of modified regions within a spectrum and thus 
allows rapid identification of multiple PTMs in a peptide, obviating search space explosion 
by inspecting PTMs only in the modified regions of a peptide. 
The tag chain algorithm resists de novo sequencing errors, whereas most tag-based 
approaches depend critically on good de novo interpretations. This approach is scalable and 
performs well even when more than 900 types of modification are considered and the 
number of potential PTMs in a peptide increases. Compared with established tools, MODi 
reliably identifies a greater variety of modification types in multiply modified peptides and 
even detects modifications of low abundance. 
Another new algorithm called “DBond” analyzes disulfide linked peptides based on specific 
features of disulfide bonds (Choi et al., 2010). Identifying the sites of disulfide bonds in a 
protein is essential for thorough understanding of a protein’s tertiary and quaternary 
structures and its biological functions. Disulfide linked peptides are usually identified 
indirectly by labeling free sulfhydryl groups with alkylating agents, followed by chemical  
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Fig. 5. One example of comprehensive identifications of PTMs in cellular GAPDH (cited 
from Seo et al., 2008). 
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Fig. 6. Overview of MODi algorithm (cited from Na et al., 2008). 
reduction and mass spectral comparison or by detecting the expected masses of disulfide 
linked peptides on mass scan level. However, these approaches for determination of 
disulfide bonds become ambiguous when the protein is highly bridged and modified. For 
accurate identification of disulfide linked peptides, we developed an algorithmic solution 
for the analysis of MS/MS spectra of disulfide bonded peptides under non-reducing 
condition. To determine disulfide linked sites, DBond takes into account fragmentation 
patterns of disulfide linked peptides in nucleoside diphosphate kinase (NDPK) as a model 
protein, considering fragment ions including cysteine, cysteine thioaldehyde (-2 Da), 
cysteine persulfide (+32 Da) and dehydroalanine (-34 Da). Using this algorithm, we 
successfully identified about a dozen novel disulfide bonds in a hexa EF-hand calcium 
binding protein secretagogin and in methionine sulfoxide reductase. We believe that 
DBond, which takes into account disulfide bond fragmentation characteristics and post-
translational modifications, offers a novel approach for automatic identification of unknown 
disulfide bonds as well as their sites in proteins from MS/MS spectra (Choi et al., 2010).  
2.2.4 Examples of multiply modified proteins  
Employing SEMSA, a sensitive mass spectrometric method for detecting low abundant 
protein modifications, and MODi and DBond algorithm for searching for unknown 
modifications of separated protein on 2D-PAGE, we characterized the nature as well as the 
relative abundances of these hitherto unknown Cys modifications in cellular GAPDH 
purified on 2D-PAGE (Jeong et al., 2011). We found unexpected mass shifts at active site Cys 
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residue (ΔM = -16, -34 and +64 Da) in addition to those of previously known oxidation 
products including sulfinic and sulfonic acids, and disulfide bonds. Similar changes were 
also found in other ROS-sensitive proteins including NDPK A, PRX6 and mitochondrial 
proteins. Mass differences of -16, -34 and +64 Da are presumed to reflect the conversion of 
Cys to Ser, DHA and Cys–SO2-SH respectively. The plausible pathways leading to their 
formation from Cys were deduced from the distribution of the disulfide bonds and were 
confirmed in model systems by analyzing three dimensional protein structures and by 
employing model chemical reactions. Also sulfenic and sulfinic acids were detected as 
acrylamide adducts (ΔM = +87 and +103 Da) in samples on SDS-PAGE. These findings 
suggest that diverse modifications of redox-active Cys can be generated by ROS. These 
findings of unknown modifications are due to the sensitive mass spectrometric method, 
SEMSA, and unrestricted PTM search tool, MODi and DBond. These strategies should lead 
to identification of many unknown modifications which doubtless occur in various 
signaling pathways and in health and disease.  
Combining 2D-PAGE for separating heterogenous population of one protein, SEMSA for 
analyzing low abundant modified peptide with MS/MS and MODi for searching algorithm 
to identify novel and multiple modifications, makes it possible to identify multiple and low 
abundant modifications of protein comprehensively. 
3. Conclusion  
Many protein modifications including amino acid substitutions, alternative splicing and 
post-translational modifications regulate the various biological functions of proteins by 
altering the protein-protein interactions, protein localization and protein activity. 
Understanding the relationship between protein modifications and their physiological 
activities will help define the principles on biological regulation. To demonstrate the exact 
protein function and its regulation, comprehensive identifications of low abundant and 
unexpected modification is essential. For the comprehensive identification of PTMs, peptide 
sequencing using tandem MS can give the most effective results. However, identification of 
PTMs does not simple as protein identification using MS. The enrichment of low abundant 
PTMs is necessary. Because most enrichment approaches of many type of PTMs are 
insufficient, we suggest the use of a combination of approaches: first separating the 
heterogeneous populations of a protein with multiple modifications on 2D-PAGE, then 
comprehensively identifying the PTMs employing SEMSA of MS/MS for detecting low 
abundant modifications and raising peptide coverage up to 100%, and searching MS/MS 
spectra using searching algorithm MODi for multiple and unexpected modifications. With 
these combined powerful proteomic tools, it will be possible to discover hitherto unknown 
PTMs in proteins, that influence various signaling pathways. This will hold the key for fully 
understanding the roles of proteins in biological and pathological processes in molecular 
level.  
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